Colour enhancement

From PsychonautWiki
(Redirected from Property:Colour enhancement)
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
4-HO-DPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
2C-P
2C-C
MiPLA
3-MeO-PCE
Tree.jpgJapanese Garden by Anonymous
LSD
MiPT
Psilocybin mushrooms
5-MeO-DiBF
TMA-2
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
5-Hydroxytryptophan
Ayahuasca
Experience:1mg 25c-NBOMe - Experiment in my room
3C-E
25C-NBOMe
25B-NBOH
Proscaline
Omberacetam
4-AcO-DMT
Psilocin
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
DiPT
Experience:1050 µg 1cP-LSD - The matrix
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
6-APB
2C-T-7
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:3-MeO-PCP - Extreme psychosis
Phenethylamine (compound)
25C-NBOH
4-AcO-DiPT
Mescaline
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
25I-NBOH
3-MMC
2C-B-FLY
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Cannabis
Memantine
THJ-018
5F-PB-22
Escaline
Efavirenz
Experience:40mg - Brothermind and the Forest's Hand
Phenylpiracetam
Experience:300µg LSD - Togetherness and the Silent Dusk
4-FA
4-AcO-MET
LSA
1B-LSD
2C-T-21
EPT
Experience:4x 200ug tabs - You do not need to understand
JWH-073
Experience:2 tabs DOB - My DOB Nightmare
Allylescaline
DET
2C-T-2
MDA
ALD-52
5-MeO-MiPT
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Selective serotonin reuptake inhibitor
4-HO-EPT
ΑMT
Experience:800 seeds LSA - My First Trip Ever
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
DPT
2C-B
AL-LAD
Methallylescaline
PARGY-LAD
Experience:250mg DXM - DXM Itch and Trip Report
Chur City in Switzerland.jpgChur, Switzerland by Naps284
25I-NBOMe
2C-H
2C-I
6-APDB
DOI
4-HO-DiPT
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Bufotenin
Amanita muscaria
Experience:337mg DMT fumarate - A Day With DMT
25B-NBOMe
ETH-LAD
MDAI
Experience:4-AcO-DMT + 200mg Pill
Experience:120mg - Garden of The Gods
Enhancement of colour rose.jpgRose by Chelsea Morgan
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
4-HO-MET
THJ-2201
Experience:~150mg MDA(oral) - a case of mistaken identity
Ibogaine
DOC
DMT
MPT
Experience:4-HO-MiPT / A care free psychedelic getaway
MDEA
2C-E
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
MDMA
DOM
Pregabalin
Aniracetam
5-MeO-DALT
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
25D-NBOMe
4-HO-MPT
4-AcO-MiPT
2C-D
Coluracetam
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Βk-2C-B
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
JWH-018
5-MeO-DiPT
Chameleon.jpgChameleon by Anonymous.
Experience:1000 Morning Glory seeds - Rediscovering the Self
Paradise island by Xanny.jpgParadise island by Subsentience
1P-LSD
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
LSZ
Experience:25mg 3-MeO-PCP - Enhanced film experience
25N-NBOMe
Bromo-DragonFLY
1P-ETH-LAD
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
DOB
GABAergic hallucinogens
MET
TMA-6
Experience:BK-2C-B - Various experiences
4-AcO-DET
PRO-LAD
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Oxiracetam
Pramiracetam
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:4.5g - The Grand Introduction to Beauty and Fear
Piracetam
4-HO-MiPT
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
4-HO-DET
LSM-775

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.